Home › Trial NCT07406594
Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer
- Trial IDNCT07406594
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Vermont Medical Center
- Enrollment12
- Start date2027-10
- ConditionsBreast Cancer · HER-2 Positive Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.